StockData
Dogwood Therapeutics, Inc. logo

Dogwood Therapeutics, Inc. (DWTX) stock

DWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.08+0.02 (+1.89%)

Close on Nov 17, 2026Market cap $36.71MP/E –Yield –

Dogwood Therapeutics cash

Cash and short-term investments held at the end of each period.

Dogwood Therapeutics's cash was $9.61M at Jun 30, 2026. For fiscal 2025 it was $6.52M, down 56.1% from the year before. The highest annual figure on record is $29.80M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.52M-56.1%
FY2024Dec 31, 2024$14.85M+347.6%
FY2023Dec 31, 2023$3.32M-52.8%
FY2022Dec 31, 2022$7.03M-49.8%
FY2021Dec 31, 2021$14.01M-53.0%
FY2020Dec 31, 2020$29.80M+9530.5%
FY2019Dec 31, 2019$309.38K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.61M-28.3%
Q1 FY2026Mar 31, 2026$13.23M-24.6%
Q4 FY2025Dec 31, 2025$6.52M-56.1%
Q3 FY2025Sep 30, 2025$10.13M+396.5%
Q2 FY2025Jun 30, 2025$13.40M+343.8%
Q1 FY2025Mar 31, 2025$17.54M+637.1%
Q4 FY2024Dec 31, 2024$14.85M+347.6%
Q3 FY2024Sep 30, 2024$2.04M-57.4%
Q2 FY2024Jun 30, 2024$3.02M-34.2%
Q1 FY2024Mar 31, 2024$2.38M-55.4%
Q4 FY2023Dec 31, 2023$3.32M-52.8%
Q3 FY2023Sep 30, 2023$4.79M-51.1%
Q2 FY2023Jun 30, 2023$4.59M-40.3%
Q1 FY2023Mar 31, 2023$5.33M-53.0%
Q4 FY2022Dec 31, 2022$7.03M-49.8%
Q3 FY2022Sep 30, 2022$9.79M-49.0%
Q2 FY2022Jun 30, 2022$7.70M-64.8%
Q1 FY2022Mar 31, 2022$11.35M-53.8%
Q4 FY2021Dec 31, 2021$14.01M-53.0%
Q3 FY2021Sep 30, 2021$19.19M+3744.3%
Q2 FY2021Jun 30, 2021$21.84M+1982.5%
Q1 FY2021Mar 31, 2021$24.59M+1958.2%
Q4 FY2020Dec 31, 2020$29.80M+9530.5%
Q3 FY2020Sep 30, 2020$499.08K–
Q2 FY2020Jun 30, 2020$1.05M–
Q1 FY2020Mar 31, 2020$1.19M–
Q4 FY2019Dec 31, 2019$309.38K–

More Dogwood Therapeutics figures

See a number that looks wrong?